AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17576207 — intervention group
Group type: EXPERIMENTAL
Intervention: High peak plasma concentrations of 5‐ASA
Number of subjects: 24
Study 15076792 — intervention group
Group type: EXPERIMENTAL
Intervention: 4C model (gold standard)
Number of subjects: 27
Study 15076792 — intervention group
Group type: EXPERIMENTAL
Intervention: 3Cw model
Number of subjects: 27
Study 15076792 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive methods (DXA, BMI, skinfold measurement, bioimpedance)
Number of subjects: 27
Study 15076792 — intervention group
Group type: EXPERIMENTAL
Intervention: 3Cb model
Number of subjects: 27
Study 15076792 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction equation based on BMI
Number of subjects: 27
Study 12238418 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary coronary stent implantation
Number of subjects: 479
Study 12238418 — intervention group
Group type: COMPARATOR
Intervention: Optimal PTCA with provisional stenting
Number of subjects: 479
Study 12238418 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stent strategy
Number of subjects: 479
Study 9869017 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine 10-40 mg daily, captopril 12.5-50.0 mg daily, hydrochlorothiazide 12.5-50.0 mg daily)
Number of subjects: 2394
Study 9869017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2394
Study 8005305 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist therapy for 12 weeks
Number of subjects: 80
Study 8005305 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control group)
Number of subjects: 80
Study 2806500 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-conserving reservoir device (Oxymizer Pendant)
Number of subjects: 36
Study 2806500 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal catheter
Number of subjects: 36
Study 2806500 — intervention group
Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 36
Study 985049 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine plus tryptophan
Number of subjects: 24
Study 985049 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine plus placebo
Number of subjects: 24
Study 31408531 — intervention group
Group type: EXPERIMENTAL
Intervention: MYC translocation (n = 42)
Number of subjects: 130
Study 31408531 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-hit translocation (n = 31)
Number of subjects: 130
Study 31408531 — intervention group
Group type: COMPARATOR
Intervention: No MYC translocation (n = 35)
Number of subjects: 130
Study 31408531 — intervention group
Group type: COMPARATOR
Intervention: No double-hit translocation (n = 46)
Number of subjects: 130
Study 31408531 — intervention group
Group type: EXPERIMENTAL
Intervention: MYC translocation
Number of subjects: 130
Study 31408531 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-hit translocation
Number of subjects: 130
Study 31408531 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-germinal centre type
Number of subjects: 130
Study 28334771 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 360 mg every 84 days
Number of subjects: 155
Study 28334771 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 480 mg every 84 days
Number of subjects: 155
Study 25287168 — intervention group
Group type: EXPERIMENTAL
Intervention: 280 mg of acid‐resistant lipase
Number of subjects: 16
Study 25287168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 23877927 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose solution
Number of subjects: 87
Study 23877927 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 87
Study 21471801 — intervention group
Group type: EXPERIMENTAL
Intervention: Active subdiaphragmatic gas aspiration (n=52)
Number of subjects: 104
Study 21471801 — intervention group
Group type: COMPARATOR
Intervention: Simple evacuation (n=52)
Number of subjects: 104
Study 18535812 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIT (Subcutaneous Immunotherapy)
Number of subjects: 0
Study 18535812 — intervention group
Group type: COMPARATOR
Intervention: SLIT (Sublingual Immunotherapy)
Number of subjects: 0
Study 16582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C serum levels
Number of subjects: 41
Study 16582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin clearance
Number of subjects: 41
Study 16582575 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum creatinine levels
Number of subjects: 41
Study 12546249 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshly prepared foods (15 MJ, 3,600 kcal)
Number of subjects: 33
Study 12546249 — intervention group
Group type: COMPARATOR
Intervention: Full CRP (15 MJ, 3,600 kcal)
Number of subjects: 33
Study 12546249 — intervention group
Group type: COMPARATOR
Intervention: One-half CRP (7.5 MJ, 1,800 kcal)
Number of subjects: 33
Study 11789206 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus plus ligustrazine
Number of subjects: 24
Study 11789206 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus
Number of subjects: 24
Study 11789206 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligustrazine
Number of subjects: 24
Study 11789206 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 8903697 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric arm exercises
Number of subjects: 6
Study 8903697 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular plane arm elevation and arm abduction
Number of subjects: 6
Study 2052117 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium aspartate
Number of subjects: 22
Study 2052117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6139628 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D or alfacalcidol treatment; specific dosage and duration not mentioned.
Number of subjects: 0
Study 6139628 — intervention group
Group type: COMPARATOR
Intervention: Reference range based on biochemical measurements and biopsy results; no specific control group mentioned.
Number of subjects: 0
Study 31192938 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-row circular stapler (Mirus Disposable Circular Stapler 3 Row 29)
Number of subjects: 154
Study 31192938 — intervention group
Group type: COMPARATOR
Intervention: 2-row circular stapler (Ethicon 29 mm Curved Intraluminal Stapler)
Number of subjects: 154
Study 28146245 — intervention group
Group type: EXPERIMENTAL
Intervention: AFXL pretreatment
Number of subjects: 12
Study 28146245 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdermabrasion
Number of subjects: 12
Study 28146245 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 12
Study 28146245 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 12
Study 28146245 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-AFXL pretreatment
Number of subjects: 12
Study 28146245 — intervention group
Group type: COMPARATOR
Intervention: Methyl aminolevulinate-treated controls
Number of subjects: 12
Study 28146245 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 12
Study 25574609 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting digit flexors (DF)
Number of subjects: 11
Study 25574609 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting elbow flexors (EF)
Number of subjects: 11
Study 25574609 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting lumbar flexors (LF)
Number of subjects: 11
Study 25574609 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefatiguing exercise targeting shoulder adductors (SA)
Number of subjects: 11
Study 25574609 — intervention group
Group type: COMPARATOR
Intervention: Control climb (no prefatiguing exercise)
Number of subjects: 11
Study 25311158 — intervention group
Group type: EXPERIMENTAL
Intervention: NHP (medicinal herb-based natural health product)
Number of subjects: 30
Study 25311158 — intervention group
Group type: COMPARATOR
Intervention: Control (negative control)
Number of subjects: 30
Study 22476240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (100 mg preoperatively, then 50 mg every 12 hrs)
Number of subjects: 60
Study 22476240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19608565 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) for final oocyte maturation
Number of subjects: 0
Study 19608565 — intervention group
Group type: COMPARATOR
Intervention: hCG for final oocyte maturation
Number of subjects: 0
Study 19608565 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase rescue with GnRHa
Number of subjects: 0
Study 17890944 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy without thalidomide
Number of subjects: 668
Study 17890944 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with thalidomide
Number of subjects: 668
Study 15375808 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery program
Number of subjects: 46
Study 15375808 — intervention group
Group type: COMPARATOR
Intervention: Conventional functional training intervention
Number of subjects: 46
Study 11124927 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic incision device
Number of subjects: 100
Study 11124927 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual lancet
Number of subjects: 100
Study 11124927 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 11511333 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated protein C (APC)
Number of subjects: 500
Study 11511333 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain management techniques
Number of subjects: 500
Study 11511333 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel markers of neurotrauma
Number of subjects: 500
Study 11511333 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants in bypass surgery
Number of subjects: 500
Study 9262046 — intervention group
Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 0
Study 9262046 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study 8316266 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 1012
Study 8316266 — intervention group
Group type: COMPARATOR
Intervention: Coronary angioplasty
Number of subjects: 1012
Study 2436415 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% dithranol sticks (Ditrastick)
Number of subjects: 30
Study 2436415 — intervention group
Group type: COMPARATOR
Intervention: 4% butantrone sticks
Number of subjects: 30
Study 30360635 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST Club physical activity intervention (2 sessions/week for 8 weeks)
Number of subjects: 30
Study 30360635 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study 27525826 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment for 4 weeks, using two acupoints: Baihui and Shenting
Number of subjects: 61
Study 27525826 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what treatment they received)
Number of subjects: 61
Study 24566820 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multiple health behavior change program
Number of subjects: 352
Study 24566820 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment control condition
Number of subjects: 352
Study 22197012 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-recumbent position (30°)
Number of subjects: 229
Study 22197012 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 229
Study 20192923 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromogranin A detection in saliva of type 2 diabetic patients
Number of subjects: 60
Study 20192923 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 60
Study 18462423 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL plus BTX (8 U total dose, 0.1 mL intradermal injections in one cheek)
Number of subjects: 15
Study 18462423 — intervention group
Group type: COMPARATOR
Intervention: IPL plus saline (control group)
Number of subjects: 15
Study 18462423 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL plus BTX
Number of subjects: 15
Study 18462423 — intervention group
Group type: COMPARATOR
Intervention: IPL plus saline
Number of subjects: 15
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drug treatment
Number of subjects: 560
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: No modifications to drug treatment
Number of subjects: 560
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of antihypertensive drugs taken
Number of subjects: 560
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of antihypertensive drug modifications
Number of subjects: 560
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician contacts
Number of subjects: 560
Study 16378562 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension-related consultations
Number of subjects: 560
Study 12634972 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 36
Study 12634972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10576361 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical prosthesis coupled to an anti-reflux valve system (group 2)
Number of subjects: 22
Study 10576361 — intervention group
Group type: COMPARATOR
Intervention: Esophageal prosthesis without anti-reflux valve mechanism (group 1)
Number of subjects: 22
Study 10576361 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 22
Study 8629830 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 0
Study 8629830 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapies (not specified)
Number of subjects: 0
Study 1670907 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright tilt-table test with isoproterenol infusion (1 to 3 micrograms/minute)
Number of subjects: 25
Study 1670907 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy with beta-blockers, disopyramide, transdermal scopolamine, or hydroflurocortisone
Number of subjects: 25
Study 1670907 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study 31132897 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.25% desoximetasone spray with twice daily phone call reminders
Number of subjects: 12
Study 29374668 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership (NFP) plus existing services
Number of subjects: 400
Study 29374668 — intervention group
Group type: COMPARATOR
Intervention: Existing services (comparison group)
Number of subjects: 400
Study 26956140 — intervention group
Group type: EXPERIMENTAL
Intervention: SEE IT training during three outpatient SPI visits over a 1-month period
Number of subjects: 52
Study 26956140 — intervention group
Group type: COMPARATOR
Intervention: Single SPI visit with a diabetes treatment video
Number of subjects: 52
Study 26956140 — intervention group
Group type: EXPERIMENTAL
Intervention: SEE IT training
Number of subjects: 52
Study 24052275 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 12
Study 24052275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 22416902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 66
Study 22416902 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 66
Study 20077249 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic product before manufacturing change
Number of subjects: 0
Study 20077249 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic product after manufacturing change
Number of subjects: 0
Study 20077249 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional statistical methods (two one‐sided testing, Kolmogorov‐Smirnov test)
Number of subjects: 0
Study 20077249 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlap coefficient method
Number of subjects: 0
Study 20077249 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulatory considerations
Number of subjects: 0
Study 18230864 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-thickened liquids
Number of subjects: 711
Study 18230864 — intervention group
Group type: EXPERIMENTAL
Intervention: Nectar-thickened liquids
Number of subjects: 711
Study 18230864 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin-down posture
Number of subjects: 711
Study 17196058 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 or 20 mg/day)
Number of subjects: 234
Study 17196058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 15493437 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual attention therapy (12 one-hour sessions, computer-based)
Number of subjects: 30
Study 15493437 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 30
Study 11101481 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylloquinone (1000 microg daily for 2 weeks)
Number of subjects: 219
Study 11101481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 8956929 — intervention group
Group type: COMPARATOR
Intervention: Tiagabine (30 mg/day)
Number of subjects: 37
Study 8956929 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (mean 65.7 mg/day, range 30-80 mg/day)
Number of subjects: 37
Study 8956929 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiagabine (mean 67.6 mg/day, range 24-80 mg/day)
Number of subjects: 37
Study 1488558 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 41740 long-term treatment for 6 months
Number of subjects: 40
Study 1488558 — intervention group
Group type: COMPARATOR
Intervention: RU 41740 standard treatment for 3 months
Number of subjects: 40
Study 3994008 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine in dextrose
Number of subjects: 2
Study 3994008 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine in dextrose plus epinephrine
Number of subjects: 2
Study 31437659 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine lozenge before training sessions
Number of subjects: 25
Study 31437659 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge before training sessions
Number of subjects: 25
Study 29257986 — intervention group
Group type: EXPERIMENTAL
Intervention: High n-3 LCPUFA marine fish intake
Number of subjects: 0
Study 27772558 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative group intervention (CGI) with 10 group sessions over 3 months and 2 booster sessions at 6 and 12 months after baseline.
Number of subjects: 300
Study 27772558 — intervention group
Group type: COMPARATOR
Intervention: Enhanced medical care (control group).
Number of subjects: 300
Study 27772558 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative group intervention (CGI).
Number of subjects: 300
Study 24650860 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intervention (n=552)
Number of subjects: 1733
Study 24650860 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous intervention (n=517)
Number of subjects: 1733
Study 24650860 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n=664)
Number of subjects: 1733
Study 22529255 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT) with fluorouracil (FU)
Number of subjects: 823
Study 22529255 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemoradiotherapy (CRT) with fluorouracil (FU)
Number of subjects: 823
Study 19793169 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 liter PEG with 200 mg dimethylpolysiloxane 3 hours before CE
Number of subjects: 40
Study 19793169 — intervention group
Group type: COMPARATOR
Intervention: Fasted only
Number of subjects: 40
Study 18579907 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum dorsiflexor moment during walking at increasing speeds (70, 80, 90, 100, and 110% of PTS)
Number of subjects: 16
Study 18579907 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition from walking to running at the preferred transition speed (PTS)
Number of subjects: 16
Study 15715188 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clarithromycin (Klaricid XL) once-daily for 3 months
Number of subjects: 67
Study 15715188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 11830814 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroplasty and electrocautery
Number of subjects: 146
Study 11830814 — intervention group
Group type: COMPARATOR
Intervention: Chondroplasty alone (Control)
Number of subjects: 146
Study 10090328 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (15 p.p.m.)
Number of subjects: 9
Study 10090328 — intervention group
Group type: COMPARATOR
Intervention: Control (without inhaled nitric oxide)
Number of subjects: 9
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 19
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (10 or 15 mg)
Number of subjects: 19
Study 7751833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose training phase
Number of subjects: 19
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported effects of diazepam
Number of subjects: 19
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported effects of buspirone
Number of subjects: 19
Study 7751833 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported effects of both drugs
Number of subjects: 19
Study 2256458 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple pollen extract
Number of subjects: 0
Study 2256458 — intervention group
Group type: COMPARATOR
Intervention: Birch pollen
Number of subjects: 0
Study 399857 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing weekly injections of house dust mite extract for 18 weeks followed by monthly injections to complete 18 months of treatment
Number of subjects: 56
Study 399857 — intervention group
Group type: COMPARATOR
Intervention: Similar injections for 18 weeks followed by placebo injections up to 18 months
Number of subjects: 56
Study 399857 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections for 18 months
Number of subjects: 56